JENCY SAMUEL: Open Payments
NPI 1699080655 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 40 payments from 13 companies in 2025. Trend: 2023 $1,505 · 2024 $1,283 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $177 |
| Abbott Laboratories | 5 | $105 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $103 |
| Novo Nordisk Inc | 4 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $76 |
| Lilly USA, LLC | 3 | $73 |
| Gilead Sciences, Inc. | 2 | $40 |
| SANOFI-AVENTIS U.S. LLC | 1 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
Products named: FREESTYLE LIBRE 3, XIFAXAN, JARDIANCE, MOUNJARO, RINVOQ, QULIPTA, UBRELVY, Wegovy.
Industry payments across NY — which companies pay providers there.
